Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

40 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Consensus on Prostate Cancer Treatment of Localized Disease With Very Low, Low, and Intermediate Risk: A Report From the First Prostate Cancer Consensus Conference for Developing Countries (PCCCDC).
Luz MA, Guimarães GC, Nardi AC, Pompeo ASFL, Sarkis ÁS, Nowier A, Lima Pompeo AC, Nardozza A Jr, Adamy A Jr, Carneiro A, Salvajoli BP, Benigno BS, Freitas CH Jr, Chade CADC, Palhares DMF, Otero DAC, Neto DCVDS, Carvalhal EF, Gil E, Freire de Arruda F, Korkes F, Caserta Lemos G, Carvalhal GF, de Carvalho ÍT, Gimpel IFP, Chambô JL, Pontes J Jr, Filho LAR, Nogueira LM, Wroclawski ML, Freitas MRP, Arap MA, Sadi MV, Bulbul M, Coelho RF, Gadia R, Khauli RB, Dos Reis RB, Rojas RAL, Guimarães RG, Aldousari S, Ferrigno R. Luz MA, et al. Among authors: gadia r. JCO Glob Oncol. 2021 Apr;7:523-529. doi: 10.1200/GO.20.00515. JCO Glob Oncol. 2021. PMID: 33856894 Free PMC article.
Treatment of Localized and Locally Advanced, High-Risk Prostate Cancer: A Report From the First Prostate Cancer Consensus Conference for Developing Countries.
Khauli R, Ferrigno R, Guimarães G, Bulbulan M, Uson Junior PLS, Salvajoli B, Palhares DMF, Racy D, Gil E, de Arruda FF, Lemos GC, Carvalhal GF, de Carvalho IT, Martins IAF, Gimpel IFP, Salvajoli JV, Chambo JL, Pontes J Jr, Filho LAR, Nogueira L, Freitas MRP, Wroclawski M, Arap MA, Sadi MV, Coelho R, Gadia R, Roja RAL, Hanriot RM, Baroni R, Zequi S, Nahas WC, Alfer W Jr, Maluf FC. Khauli R, et al. Among authors: gadia r. JCO Glob Oncol. 2021 Apr;7:530-537. doi: 10.1200/GO.20.00421. JCO Glob Oncol. 2021. PMID: 33856890 Free PMC article.
Hypofractioned radiotherapy in prostate cancer: is it the next step?
Moraes FY, Siqueira GM, Abreu CE, da Silva JL, Gadia R. Moraes FY, et al. Among authors: gadia r. Expert Rev Anticancer Ther. 2014 Nov;14(11):1271-6. doi: 10.1586/14737140.2014.972380. Expert Rev Anticancer Ther. 2014. PMID: 25367322 Review.
Long-term outcomes of dose-escalated intensity modulated radiation therapy alone without androgen deprivation therapy for patients with intermediate and high-risk prostate cancer.
Gadia R, Teixeira Leite ET, Bierrenbach AL, Ynoe de Moraes F, Spratt DE, Arruda FF, Cintra Vita Abreu CE, Fernandes da Silva JL, de Andrade Carvalho H, Garicochea B. Gadia R, et al. Adv Radiat Oncol. 2016 Oct 29;1(4):300-309. doi: 10.1016/j.adro.2016.10.006. eCollection 2016 Oct-Dec. Adv Radiat Oncol. 2016. PMID: 28740901 Free PMC article.
International Multicenter Validation of an Intermediate Risk Subclassification of Prostate Cancer Managed with Radical Treatment without Hormone Therapy.
Berlin A, Moraes FY, Sanmamed N, Glicksman R, Koven A, Espin-Garcia O, Leite ETT, Silva JLF, Gadia R, Nesbitt M, Catton CN, Kaffenberger S, Salami SS, Morgan TM, Hearn JWD, Jackson WC, Mehra R, Chung P, Fleshner NE, Zumsteg ZS, Dess RT, Feng FY, Finelli A, Spratt DE. Berlin A, et al. Among authors: gadia r. J Urol. 2019 Feb;201(2):284-291. doi: 10.1016/j.juro.2018.08.044. J Urol. 2019. PMID: 30153435
40 results